当前位置：
X-MOL 学术
›
J. Neurol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
When should we consider chronic patients as non-responders to monoclonal antibodies targeting the CGRP pathway?
Journal of Neurology ( IF 4.8 ) Pub Date : 2021-08-28 , DOI: 10.1007/s00415-021-10772-7 Claudia Altamura 1 , Sabina Cevoli 2 , Nicoletta Brunelli 1 , Cinzia Aurilia 3 , Luisa Fofi 3 , Gabriella Egeo 3 , Piero Barbanti 3, 4 , Fabrizio Vernieri 1 ,
中文翻译：
我们何时应将慢性患者视为对靶向 CGRP 通路的单克隆抗体无反应者？
更新日期：2021-08-28
Journal of Neurology ( IF 4.8 ) Pub Date : 2021-08-28 , DOI: 10.1007/s00415-021-10772-7 Claudia Altamura 1 , Sabina Cevoli 2 , Nicoletta Brunelli 1 , Cinzia Aurilia 3 , Luisa Fofi 3 , Gabriella Egeo 3 , Piero Barbanti 3, 4 , Fabrizio Vernieri 1 ,
Affiliation
中文翻译：
我们何时应将慢性患者视为对靶向 CGRP 通路的单克隆抗体无反应者？
京公网安备 11010802027423号